UPB
Upstream Bio
$6.40
−$0.01 (−0.16%)Jul 27, 2026
Key metrics
The numbers that frame UPB today
- Market cap
- $348.29M
- P/E (TTM)
- -2.2
- EV / FCF
- -1.8
- Gross margin
- 100%
- EV / Sales
- 76.0
- ROIC
- -55.9%
- Div yield
- 0%
- Debt / equity
- 0.0
- 52wk Low
- $5.85
- 52wk High
- $33.68
Growth
Revenue and earnings trend for UPB
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about UPB
Is Upstream Bio a good buy?
No. Upstream Bio has poor quality and poor momentum. Both signals point to a weaker setup. Growth looks poor. That could put pressure on the long-term business case. We think Upstream Bio is selling at a very high price.
What is the market capitalization of UPB?
Upstream Bio's market capitalization is $348.29M.
What is the P/E ratio for UPB stock?
Upstream Bio's current P/E ratio is -2.2.
What is the 52-week high for UPB stock?
The 52-week high for Upstream Bio is $33.68. The current close of $6.40 is 81% below that high.
What is the 52-week low for UPB stock?
The 52-week low for Upstream Bio is $5.85. The current close of $6.40 is 9.4% above that low.
Does UPB stock pay dividends?
Upstream Bio does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for UPB?
Upstream Bio's Debt / Equity ratio is 0.